CN101322733B - Chinese herbal medicine formulation for treating pollution lung disease - Google Patents
Chinese herbal medicine formulation for treating pollution lung disease Download PDFInfo
- Publication number
- CN101322733B CN101322733B CN2008101405090A CN200810140509A CN101322733B CN 101322733 B CN101322733 B CN 101322733B CN 2008101405090 A CN2008101405090 A CN 2008101405090A CN 200810140509 A CN200810140509 A CN 200810140509A CN 101322733 B CN101322733 B CN 101322733B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese herbal
- clearing away
- lung
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal preparation for treating polluting lung diseases, the preparation can prevent and treat respiratory tract and lung discomfort diseases caused by poor air condition, the medicine of the invention chooses ballonflower liquid extract, honeysuckle, wild chrysanthemum, fructus momordicae, dandelion, lotus leaf and licorice, the medicinal substances are combined to cause the efficacies of the medicinal substances to produce a synergism, thus efficiently clearing away dust particles deposited in alveolus, nourishing qi and clearing away the fire, supporting the healthy energy and improving immunity; by combining the medicinal substances, compared with the prior art, the Chinese herbal preparation of the invention has the advantages of no toxic and side effect, overall consideration of superficiality and origin, combination of prevention and treatment, and being capable of clearing away the dust particles deposited in the alveolus more effectively, thus nourishing qi, clearing away the fire, and supporting the healthy energy.
Description
Affiliated technical field
The invention belongs to the technical field of Chinese medicines field, be specifically related to a kind of Chinese herbal and crude drugs preparations for the treatment of infectious pulmonary disease, said preparation can prevent and treat because of the air conditions difference and cause the uncomfortable disease of respiratory tract and pulmonary.
Background technology
Industrial waste gas, vehicle exhaust, city floating dust, classroom dust etc. are poor because of air conditions, form lungs the absorbance of oxygen lowly caused blood and big cerebral oxygen supply deficiency, the poor sleeping quality that causes, lethargy, be short of physical strength, depletion fire syndrome going up, vigour sink, hypoimmunity.Clinical this disease drug that is used for the treatment of, how based on anti-inflammation: the probiotics human body during its anti-inflammation is killed simultaneously, cause dysbacteriosis, hypoimmunity easily, at the antiviral leukocyte that kills simultaneously in the blood, take for a long time and easily cause hypoimmunity as Radix Isatidis granules.
Summary of the invention
Therefore seek a kind of ideal and effectively the Natural antioxidant be the direction that many scholars make great efforts to study, people reach sedimentary micronic dust in the clear filter alveolar and support that unit relieves inflammation or internal heat, the demand of the Chinese medicine preparation of strengthening the body resistance is strong day by day, up to now, also do not find the report of any relevant pharmaceutical composition of the present invention, the inventor studies repeatedly and verifies through clinical, finally found the pure Chinese medicinal preparation of better efficacy, it not only can be eliminated active oxygen unnecessary in the body, disease resistance enhancemen, also have anti-cell aging, the effect of cancer-resisting concurrently; Thereby finished the present invention.
The purpose of this invention is to provide a kind of Chinese medicine preparation, without any side effects, giving consideration to both the incidental and fundamental, the control combination, can more efficiently clear filter alveolar in sedimentary micronic dust reach and support that unit relieves inflammation or internal heat, the pure Chinese medicinal preparation of strengthening the body resistance.
The consumption of drug component of the present invention is that the inventor gets through groping in a large number to sum up, and each amounts of components all has curative effect preferably in following weight parts.
Radix Platycodonis 10-50 part, Flos Lonicerae 5-40 part, Flos Chrysanthemi Indici 10-30 part, Fructus Momordicae 5-60 part, Herba Taraxaci 5-30 part, Folium Nelumbinis 15-40 part, Radix Glycyrrhizae 5-30 part;
Medicament selection Radix Platycodonis fluidextract of the present invention, Flos Lonicerae, Flos Chrysanthemi Indici, Fructus Momordicae, Herba Taraxaci, Folium Nelumbinis, Radix Glycyrrhizae make up, make each efficacy of drugs produce synergism these drug regimens, thereby filter sedimentary micronic dust in the alveolar effectively clearly, support that unit relieves inflammation or internal heat, strengthening the body resistance, raising immunity; Wherein select Radix Platycodonis for use: property is sweet, hot, flat, returns lung meridian; Function: dispersing lung-QI and dissipating phlegm, sore-throat relieving, evacuation of pus.Lead to lung qi and throat, determining to stop up stagnates and row's pus of carbuncle, is good with paulownia Radix Platycodonis.Flos Lonicerae: property is sweet, cold, returns lung, stomach, heart channel, function: heat-clearing and toxic substances removing, and dispelling wind and heat pathogens, lung energy dispelling wind-heat is gone in cooling blood for hemostasis, and GUIXIN again can cooling blood for hemostasis through walking blood system.Flos Chrysanthemi Indici: the property suffering, sweet, hardship is slightly cold, function: dispelling wind and heat pathogens, suppressing the hyperactive liver makes eye bright, heat-clearing and toxic substances removing.Fructus Momordicae: property is sweet, cold, function: clearing heat and moistening lung cough-relieving, laxation relieving constipation.Herba Taraxaci: the property hardship, sweet, cold, function: heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, inducing diuresis for treating stranguria syndrome.Folium Nelumbinis: the property hardship, flat, function: clearing away summer-heat, sending up the lucid YANG, hemostasis.Radix Glycyrrhizae: property is sweet, and is flat, GUIXIN, lung, spleen, stomach warp, function invigorating the spleen and replenishing QI, expelling phlegm for arresting cough, heat-clearing and toxic substances removing, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.The present invention is monarch with Radix Platycodonis, and Flos Lonicerae, Flos Chrysanthemi Indici are minister, and Fructus Momordicae, Herba Taraxaci, Folium Nelumbinis make with the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription for assistant, accent is arranged in having clearly, has that benefit, sore-throat relieving promote the production of body fluid, the effect of lung heat clearing filter dirt in transferring.The present invention filters sedimentary micronic dust in the alveolar clearly and reaches and support that unit relieves inflammation or internal heat, the main advantage of strengthening the body resistance is: 1. dust in the clearing heat and moistening lung filtering lung → cleaning respiratory system → raising lungs are to the absorbance of oxygen → the improve oxygen-supplying amount of sleep quality → enhancing to brain.2. relieve inflammation or internal heat than the more effective anti-air pollution of other drug, infection, antiviral, foster unit, and improve the lungs function, improve immunocompetence.3. have no side effect.Because the present invention adopts said medicine to make up, compared with prior art the present invention has and has no side effect, giving consideration to both the incidental and fundamental, the control combination, can more efficiently clear filter alveolar in sedimentary micronic dust reach and support that unit relieves inflammation or internal heat, the advantage of strengthening the body resistance.
The specific embodiment
The present invention is made by following bulk drugs:
Radix Platycodonis 10-50 part, Flos Lonicerae 5-40 part, Flos Chrysanthemi Indici 10-30 part, Fructus Momordicae 5-60 part, Herba Taraxaci 5-30 part, Folium Nelumbinis 15-40 part, Radix Glycyrrhizae 5-30 part.
Embodiment 1:
The present invention is made by following bulk drugs:
10 parts of paulownia Radix Platycodoniss, 15 parts of Flos Loniceraes, 8 parts of Flos Chrysanthemi Indicis, 15 parts of Fructus Momordicaes, 15 parts of Herba Taraxacis, 10 parts on Folium Nelumbinis, 5 parts in Radix Glycyrrhizae.
Embodiment 2:
The present invention is made by following bulk drugs:
20 parts of paulownia Radix Platycodoniss, 25 parts of Flos Loniceraes, 30 parts of Flos Chrysanthemi Indicis, 10 parts of Fructus Momordicaes, 10 parts of Herba Taraxacis, 15 parts on Folium Nelumbinis, 10 parts in Radix Glycyrrhizae.
Embodiment 3:
The present invention is owing to following bulk drugs is made:
25 parts of paulownia Radix Platycodoniss, 10 parts of Flos Loniceraes, 30 parts of Flos Chrysanthemi Indicis, 35 parts of Fructus Momordicaes, 25 parts of Herba Taraxacis, 20 parts on Folium Nelumbinis, 20 parts in Radix Glycyrrhizae.
Embodiment 4:
The present invention is owing to following bulk drugs is made
50 parts of paulownia Radix Platycodoniss, 30 parts of Flos Loniceraes, 25 parts of Flos Chrysanthemi Indicis, 5 parts of Fructus Momordicaes, 30 parts of Herba Taraxacis, 30 parts on Folium Nelumbinis, 30 parts in Radix Glycyrrhizae;
The present invention takes by weighing, mixes according to the said medicine weight proportion, and pulverizing, ethanol are purified, granulated, packing 10 grams one bag.
The present invention can make electuary, granule or capsule according to conventional method.
One, the major function of medicine of the present invention and therapeutic domain:
1, major function:
Sedimentary micronic dust in the clear filter alveolar, support that unit relieves inflammation or internal heat, strengthening the body resistance, raising immunity.
2, therapeutic domain:
Removing heat from the lung and relieving sorethroat toxin expelling, pharyngodynia with dryness, sensation of oppression over the chest with shortness of breath, the yellow thickness of expectorant.
3, usage and dosage:
Oral every day 2---3 times, each 10 grams, the 250ml warm boiled water, the child reduces by half.30 days is a course of treatment.
Two, the clinical observation of medicine of the present invention:
1, physical data:
Accept out-patient's 300 examples for medical treatment, the patient is divided into two groups at random, 230 examples are organized in treatment, give Drug therapy of the present invention; Matched group 70 examples have Drug therapy, and wherein 2 years old of the age minimum, maximum 78 years old, the shortest 2 months of the course of disease, the longest 6 years.Clinical treatment observation, the shortest two courses of treatment, the longest eight courses of treatment.26 examples below 20 years old in the treatment group, 21-49 year 103 examples, 50-59 year 52 examples, 51 examples more than 60 years old; The course of disease is 55 examples below 1 year, 1-3 94 examples, 2-4 55 examples, 18 examples more than 5 years; 15 examples below 20 years old in the matched group, 21-49 year 40 examples, 50-59 year 12 examples, 3 examples more than 60 years old, 5 examples more than 6 years; Two groups of patients are in mean age, the course of disease, and state of an illness aspect is in a basic balance, has comparability.
2, diagnostic criteria:
All cases all by poor sleeping quality, lethargy, be short of physical strength, depletion fire syndrome going up, vigour sink, the clinical manifestation of hypoimmunity is that diagnosis is determined in diagnostic criteria.
3, Therapeutic Method:
Therapeutic Method is under the voluntary prerequisite of patient, patient is divided into two groups at random, and 230 examples are organized in treatment, take medicine of the present invention, every day 3 times, each 10 the gram, after meal half an hour the 250ml warm boiled water, per 30 days is a course of treatment, minimum taking 4 courses of treatment, the longest taking 8 courses of treatment.Matched group 70 examples are taken existing medicine, each 10 grams, every day 3 times; Per 30 days is a course of treatment, minimum taking 4 courses of treatment, 8 courses of treatment of the longest service.
4, efficacy assessment standard (being as the criterion) with clinical symptom disappearance
Recovery from illness: sleep quality improves, energetic, antisecosis normal, asthenic fire is eliminated, vigour is replied, immunity improves does not have the bounce-back symptom.
Produce effects: sleep quality is good, antisecosis is normal, asthenic fire is eliminated, the drug withdrawal symptom that has a rebound after 30 days.
Effectively: antisecosis is normal, asthenic fire is eliminated.
Invalid: poor sleeping quality, lethargy, be short of physical strength, depletion fire syndrome going up, vigour sink, the hypoimmunity symptom does not have change substantially.
5, result and analysis (seeing Table 1)
Table 1 liang group curative effect relatively
| Group | The example number | Recovery from illness | Produce effects | Effectively | Invalid | Effective percentage (%) |
| The treatment group | 230 | 100 | 86 | 42 | 2 | 99.1 |
| Matched group | 70 | 10 | 18 | 23 | 19 | 72.9 |
Therapeutic effect obviously is better than matched group as can be seen from Table 1, and its total effective rate, cure rate (99.196,45.5%) are all apparently higher than matched group (72.9,96,14.3).
Claims (1)
- One the treatment infectious pulmonary disease the Chinese herbal and crude drugs preparations kind, it is characterized in that this Chinese herbal and crude drugs preparations is by descending bulk drugs to make: 20 parts of paulownia Radix Platycodoniss, 25 parts of Flos Loniceraes, 30 parts of Flos Chrysanthemi Indicis, 10 parts of Fructus Momordicaes, 10 parts of Herba Taraxacis, 15 parts on Folium Nelumbinis, 10 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101405090A CN101322733B (en) | 2008-07-03 | 2008-07-03 | Chinese herbal medicine formulation for treating pollution lung disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101405090A CN101322733B (en) | 2008-07-03 | 2008-07-03 | Chinese herbal medicine formulation for treating pollution lung disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101322733A CN101322733A (en) | 2008-12-17 |
| CN101322733B true CN101322733B (en) | 2011-03-23 |
Family
ID=40186534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101405090A Expired - Fee Related CN101322733B (en) | 2008-07-03 | 2008-07-03 | Chinese herbal medicine formulation for treating pollution lung disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101322733B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101693865A (en) * | 2009-10-14 | 2010-04-14 | 江苏老蚕坊蚕桑生物科技开发有限公司 | Mulberry leaf pure wine and production process thereof |
| CN106879806A (en) * | 2017-04-01 | 2017-06-23 | 武汉世霖健康产业有限公司 | A kind of method for preparing herbal tea |
| CN114287623A (en) * | 2021-12-31 | 2022-04-08 | 安徽阳光药业有限公司 | Dendrobium enzyme particle and preparation method thereof |
-
2008
- 2008-07-03 CN CN2008101405090A patent/CN101322733B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 宝平科技有限公司.四季清火凉茶饮料.《东方保健品网》.2008,http://9253_16805p.bjp321.com. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101322733A (en) | 2008-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1706436A (en) | Tranquilizing soporific Chinese medicine | |
| CN104288426A (en) | Traditional Chinese medicine lotion for treating senile cutaneous pruritus and preparation method thereof | |
| CN101502614B (en) | Medicine tea for stopping snore | |
| CN100389802C (en) | Medicine for treating and preventing chronic obstractive pneumonia | |
| CN101322733B (en) | Chinese herbal medicine formulation for treating pollution lung disease | |
| CN101278981B (en) | Medicament for treating upper respiratory tract infection in children and preparation method thereof | |
| CN102657706A (en) | Infantile anti-cold umbilical therapeutic ointment | |
| CN101129768A (en) | Oral liquid for pharyngitis | |
| CN1083719A (en) | Relieving mental strain and helping sleep Chinese patent medicine and preparation method thereof | |
| CN104225218A (en) | Traditional Chinese medicine preparation for chronic urinary infection treatment | |
| CN104623379B (en) | A kind of pharmaceutical composition for the treatment of Hand-Food-Mouth Disease | |
| CN102793870A (en) | Chinese herbal medicine for treating renal calculi | |
| CN103495130B (en) | Traditional Chinese medicine composition for treating asthma | |
| CN101933743B (en) | Traditional Chinese medical health pillow | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN103830481A (en) | Medicine for treating recurrent respiratory tract infection of children | |
| CN103446257A (en) | Herbal bagged tea for treating chronic constipation | |
| CN103446425A (en) | Herbal bagged tea bag for treating chronic pharyngitis | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN102552789A (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
| CN104958530A (en) | Traditional Chinese medicinal composition for treating infantile pneumonia | |
| CN105832885A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN101129571A (en) | Oral liquid of prunella spike | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN104825670A (en) | Traditional Chinese medicine preparation for treating gas poisoning sequelae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Zhiwu Inventor after: Liu Chengyuan Inventor after: Liu Chenyang Inventor after: Li Jingyu Inventor before: Liu Zhiwu Inventor before: Liu Chengyuan Inventor before: Liu Chengyang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU ZHIWU LIU CHENGYUAN LIU CHENGYANG TO: LIU ZHIWU LIU CHENGYUAN LIU CHENYANG LI JINGYU |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110323 Termination date: 20130703 |